Accelerating the elimination of tropical infectious diseases

TropIQ Health Sciences operates a technology platform for the discovery and development of molecules to combat insect-borne infectious diseases. TropIQ combines world-class parasitological and entomological expertise with state of the art drug discovery technologies. Through this combination, TropIQ is uniquely positioned to accelerate the development of novel medicines, vaccines and vector control measures. The company was founded in 2011 as a spin-off of the Radboud University Nijmegen Medical Center in the Netherlands.